LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
News
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Subscribe today for access to
Articles and Reports
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Whatever Happened to Those Part B Lab Test Spending Reductions?
The Protecting...
Genomenon Awarded NIH Grant to Curate the Human Genome
Ann Arbor, MI —...
Ten Indicted for Health Care Kickbacks
Ten people,...
Medicare Expands Coverage of LCDT Lung Cancer Screening
No cancer is...
More Free Content Headed Your Way
Whether you’re...
